<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01524666</url>
  </required_header>
  <id_info>
    <org_study_id>AgS-001</org_study_id>
    <nct_id>NCT01524666</nct_id>
  </id_info>
  <brief_title>Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy</brief_title>
  <official_title>Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JFK Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>JFK Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small
      fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of
      Arginine) and monitored for two months. Improvement will be noted on their response to the
      Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by
      performing autonomic function testing at the beginning and end of the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropathic Pain Questionnaire</measure>
    <time_frame>After 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>QSART &amp; ANSAR testing</measure>
    <time_frame>After 2 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Peripheral Neuropathy</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Skin Biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinic patients at JFK Med CTR
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been
             diagnosed via autonomic function testing and or skin biopsy

        Exclusion Criteria:

          -  Women who are pregnant or breast feeding, patients with history of substance abuse,
             and patients with myelopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Rosenberg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>JFK Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Rosenberg, MD</last_name>
    <phone>732-321-7010</phone>
    <email>mrosenberg@jfkhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>07712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael D Rosenberg, M.D.</last_name>
      <phone>732-321-7010</phone>
      <email>MRosenberg@JFKHealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Keynan O, Mirovsky Y, Dekel S, Gilad VH, Gilad GM. Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. Pain Med. 2010 Mar;11(3):356-68. doi: 10.1111/j.1526-4637.2010.00808.x.</citation>
    <PMID>20447305</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2012</study_first_submitted>
  <study_first_submitted_qc>February 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2012</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>JFK Medical Center</investigator_affiliation>
    <investigator_full_name>Michael Rosenberg, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Small Fiber Neuropathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

